STAT-X
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

STAT-X Trademark

Serial Number: 79345190 • Registration: 7109863

STAT-X is a trademark filed by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. on May 20, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. (27 trademarks)

21st Floor, Snibe Building,

Entity Type: 99

Trademark Details

Filing Date

May 20, 2022

Registration Date

July 18, 2023

Published for Opposition

May 2, 2023

Goods & Services

[ Pharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; Pharmaceutical preparations for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemico-pharmaceutical preparations for pharmaceutical purposes, namely, chemico-pharmaceutical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemico-pharmaceutical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; ] Medicated serums used for the functional analysis of blood coagulation and fibrinolysis; Medicated serums used for the quantitative and qualitative detection of analytes in human serum, plasma and body fluids; Medicines for serum therapy, namely, medicines for serum therapy for functional analysis of blood coagulation and fibrinolysis; Medicines for serum therapy for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Biological preparations for medical purposes, namely, biological preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; Biological preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemical preparations for pharmaceutical purposes, namely, chemical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; chemical preparations for medical purposes, namely, chemical preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; chemical preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; [ enzymes for medical purposes; enzyme preparations for medical purposes; Preparations for pharmaceutical purposes, namely, preparations for pharmaceutical purposes made of trace elements that are found in the human body for the functional analysis of blood coagulation and fibrinolysis; ] Preparations for pharmaceutical purposes made of trace elements that are found in the human body for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; [ amino acids for medical purposes; preparations of microorganisms for medical or veterinary use; ] chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; [ reagent paper for medical purposes; ] diagnostic biomarker reagents for medical purposes; [ veterinary preparations for treatment of intestinal bacteria; medicines for veterinary purposes for treatment of intestinal bacteria; biological preparations for veterinary purposes for treatment of intestinal bacteria; chemical preparations for veterinary purposes for treatment of intestinal bacteria; enzymes for veterinary purposes; enzyme preparations for veterinary purposes; ] diagnostic preparations for veterinary purposes [ ; reagent paper for veterinary purposes ]

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NURC
AMENDMENT UNDER SECTION 7 - PROCESSED
Aug 6, 2025 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 5, 2025 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jan 16, 2025 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2023 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Oct 19, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 19, 2023 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 18, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 2, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 12, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 12, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2023 TROA
REFUSAL PROCESSED BY IB
Jan 5, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 8, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 28, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 27, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2022 REPR